SCHEMBL115609

SCHEMBL115609

O=CNC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21997344 1.00 ADH1B (1.00) —
SCHEMBL19658308 1.00 ADH1B (1.00) —
Hydrochloric Acid SCHEMBL4095046 0.97 — —
Hydrochloric Acid SCHEMBL9205102 0.97 — —
SCHEMBL21088347 0.94 ADH1B (0.88) —
Bicarbonate SCHEMBL11031476 0.88 ADH1B (0.78) —
SCHEMBL115509 0.87 — —
SCHEMBL26242 0.87 — —
SCHEMBL24699314 0.86 ADH1B (0.74) —
SCHEMBL6944271 0.86 ADH1B (0.74) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3906 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119954812-A Compound with natural product structure fusion and preparation method and application thereof 中国辐射防护研究院 2025-05-09 — — CN claimed
CN-119798530-A Cellulose base film with temperature and pH stimulus response and preparation method and application thereof 佛山大学 2025-04-11 — — CN claimed
US-12018021-B2 Thiophene derivatives for the treatment of disorders caused by IgE UCB Biopharma SRL (BE) 2024-06-25 — — US claimed
US-20240199542-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2024-06-20 — — US claimed
EP-4146643-B1 NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES BAYER AG (DE) 2024-05-29 — — EP claimed
WO-2024094170-A1 INHIBITOR OF UBIQUITIN-SPECIFIC PROTEASE 1 AND USE THEREOF 深圳晶泰科技有限公司 2024-05-10 — — WO claimed
US-20240150371-A1 Compounds for the Treatment of Kinase-Dependent Disorders EXELIXIS, INC. 2024-05-09 — — US claimed
WO-2024086296-A1 COMPOUNDS USEFUL IN MODULATING EGFR AND PI3K MEKANISTIC THERAPEUTICS LLC (US) 2024-04-25 — — WO claimed
EP-3778576-B1 2-CYANOPYRIMIDIN-4-YL CARBAMATE OR UREA DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME HANLIM PHARMACEUTICAL CO LTD (KR) 2024-04-17 — — EP claimed
WO-2024068473-A1 HERBICIDE/SAFENER COMBINATION BASED ON SAFENERS FROM THE CLASS OF SUBSTITUTED [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACIDS AND THEIR SALTS BAYER AKTIENGESELLSCHAFT (DE) 2024-04-04 — — WO claimed
WO-1995018817-A1 NOVEL ADENOSINE DERIVATIVES, PREPARATION METHODS THEREFOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LABORATOIRES UPSA (FR) 1995-07-13 — — WO claimed
EP-0542867-A4 METHODS OF PREVENTING OR DECREASING TISSUE DAMAGE BY NOVEL ANTIOXIDANTS AND FREE RADICAL SCAVENGERS — 1993-07-28 — — EP claimed
EP-0542867-A1 METHODS OF PREVENTING OR DECREASING TISSUE DAMAGE BY NOVEL ANTIOXIDANTS AND FREE RADICAL SCAVENGERS GENSIA, INC. (US) 1993-05-26 — — EP claimed
US-5203907-A Herbicides BASF AKTIENGESELLSCHAFT (DE) 1993-04-20 — — US claimed
EP-0495091-A4 AICA RIBOSIDE ANALOGS — 1993-01-07 — — EP claimed
EP-0503410-A1 Isoxazol- and Isothiazol 5-carboxylic acids amids BASF Aktiengesellschaft (DE) 1992-09-16 — — EP claimed
EP-0495091-A1 AICA RIBOSIDE ANALOGS GENSIA, INC. (US) 1992-07-22 — — EP claimed
WO-1992002214-A1 AICA RIBOSIDE ANALOGS GENSIA PHARMACEUTICALS, INC. (US) 1992-02-20 — — WO claimed
WO-1992002213-A1 METHODS OF PREVENTING OR DECREASING TISSUE DAMAGE BY NOVEL ANTIOXIDANTS AND FREE RADICAL SCAVENGERS GENSIA PHARMACEUTICALS, INC. (US) 1992-02-20 — — WO claimed
US-4916128-A Thiadiazinones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1990-04-10 — — US claimed
Send feedback